↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Belgium TED contract award · ocds-ted-749318-2025

Belgium – Pharmaceutical products – Farmaceutische specialiteiten op basis van ECULIZUMAB en RAVULIZUMAB

Association iris-Achats awarded €2.5M to s.a. Amgen n.v. for Healthcare & Medical in November 2025 — one of 165 awards this buyer has made, above its typical award size.

Healthcare & Medical
12 Nov 2025
Award date
€2.5M
Contract value

Buying agency

Association iris-Achats
165 Awards
€546K Avg award
Above vs typical

Winning supplier

s.a. Amgen n.v.
8 Awards
7 Buyers
€8.3M Total won

Contract description

Belgium – Pharmaceutical products – Farmaceutische specialiteiten op basis van ECULIZUMAB en RAVULIZUMAB

Premium

Related awards · Association iris-Achats

165 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

121 more awards from this buyer · full history & CSV export

Premium

Other wins · s.a. Amgen n.v.

8 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Association iris-Achats and s.a. Amgen n.v. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up